Unknown

Dataset Information

0

Development of Streptomyces sp. FR-008 as an emerging chassis.


ABSTRACT: Microbial-derived natural products are important in both the pharmaceutical industry and academic research. As the metabolic potential of original producer especially Streptomyces is often limited by slow growth rate, complicated cultivation profile, and unfeasible genetic manipulation, so exploring a Streptomyces as a super industrial chassis is valuable and urgent. Streptomyces sp. FR-008 is a fast-growing microorganism and can also produce a considerable amount of macrolide candicidin via modular polyketide synthase. In this study, we evaluated Streptomyces sp. FR-008 as a potential industrial-production chassis. First, PacBio sequencing and transcriptome analyses indicated that the Streptomyces sp. FR-008 genome size is 7.26 Mb, which represents one of the smallest of currently sequenced Streptomyces genomes. In addition, we simplified the conjugation procedure without heat-shock and pre-germination treatments but with high conjugation efficiency, suggesting it is inherently capable of accepting heterologous DNA. In addition, a series of promoters selected from literatures was assessed based on GusA activity in Streptomyces sp. FR-008. Compared with the common used promoter ermE*-p, the strength of these promoters comprise a library with a constitutive range of 60-860%, thus providing the useful regulatory elements for future genetic engineering purpose. In order to minimum the genome, we also target deleted three endogenous polyketide synthase (PKS) gene clusters to generate a mutant LQ3. LQ3 is thus an "updated" version of Streptomyces sp. FR-008, producing fewer secondary metabolites profiles than Streptomyces sp. FR-008. We believe this work could facilitate further development of Streptomyces sp. FR-008 for use in biotechnological applications.

SUBMITTER: Liu Q 

PROVIDER: S-EPMC5640794 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Development of <i>Streptomyces</i> sp. FR-008 as an emerging chassis.

Liu Qian Q   Xiao Liping L   Zhou Yuanjie Y   Deng Kunhua K   Tan Gaoyi G   Han Yichao Y   Liu Xinhua X   Deng Zixin Z   Liu Tiangang T  

Synthetic and systems biotechnology 20160817 3


Microbial-derived natural products are important in both the pharmaceutical industry and academic research. As the metabolic potential of original producer especially <i>Streptomyces</i> is often limited by slow growth rate, complicated cultivation profile, and unfeasible genetic manipulation, so exploring a <i>Streptomyces</i> as a super industrial chassis is valuable and urgent. <i>Streptomyces</i> sp. FR-008 is a fast-growing microorganism and can also produce a considerable amount of macroli  ...[more]

Similar Datasets

| S-EPMC2592917 | biostudies-literature
| S-EPMC1472359 | biostudies-literature
| PRJNA218054 | ENA
| PRJNA319142 | ENA
| PRJNA264353 | ENA
| S-EPMC7170484 | biostudies-literature
| S-EPMC2655452 | biostudies-literature
| PRJEB41109 | ENA
| S-EPMC8297383 | biostudies-literature
| S-EPMC5105302 | biostudies-literature